Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (LIFE)
NASDAQ:LIFE
aTyr Pharma (LIFE) Stock Price & Analysis
1,708 Followers
LIFE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $2.70
Previous Close$1.86
Volume241.35K
Average Volume (3M)545.81K
Market Cap
$126.02M
Enterprise Value$38.92M
Total Cash (Recent Filing)$102.13M
Total Debt (Recent Filing)$15.22M
Price to Earnings (P/E)-1.9
Beta1.07
Next Earnings
May 08, 2024EPS Estimate
-$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding67,750,024
10 Day Avg. Volume447,651
30 Day Avg. Volume545,814
Standard Deviation0.18
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.28
Price to Sales (P/S)11.94
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.62
Enterprise Value/Gross Profit3.75
Enterprise Value/Ebitda-1.23
Forecast
1Y Price Target
$20.75Price Target Upside1033.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
aTyr Pharma News
Ownership Overview
2.72% Insiders
28.00% Mutual Funds
23.87% Other Institutional Investors
45.42% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LIFE FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was $1.08 and its highest was $2.70 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is May 08, 2024 which is in 20 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Mar 14, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.238 by -$0.012.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -$0.24.
How many shares outstanding does aTyr Pharma have?
aTyr Pharma has 67,750,020 shares outstanding.
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.238. Following the earnings report the stock price went up 22.84%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Baker Bros Advisors LP. It holds aTyr Pharma’s shares valued at N/A.
---
aTyr Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.75 (1033.88% Upside)
$20.75 (1033.88% Upside)
Blogger Sentiment
Bullish
LIFE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 8.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 20.8%
Last 30 Days ▲ 20.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.00%
12-Months-Change
Fundamentals
Return on Equity
-62.16%
Trailing 12-Months
Asset Growth
27.44%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
LIFE Earnings Call
Q4 2024
0:00 / 0:00
---
LIFE Stock 12 Months Forecast
Average Price Target
$20.75
▲(1033.88% Upside)
Technical Analysis
Best Analysts Covering LIFE
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-6.47%
reiterated a buy rating 2 months ago
Copying Sean Kim PhD's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -6.47% per trade.
---